Media Kits

Media members may access multimedia resources such as fact sheets, infographics, photos, logos, select press releases and more, all for use in stories in development.

Bamlanivimab for COVID-19

See More About Bamlanivimab

Baricitinib for COVID-19

See More About Baricitinib

Cyramza® (ramucirumab) Approved by the U.S. FDA as First-Line Treatment for Metastatic EGFR-Mutated Non-Small Cell Lung Cancer

Read More About Cyramza

Retevmo™ (selpercatinib): First Therapy Specifically for Patients with Advanced RET-Driven Cancers Is Approved

Read More About Retevmo

woman teaching a girl to ride a bike

Reyvow™ (lasmiditan) C-V: A First-in-Class Acute Treatment for Migraine Is Now Available

Read More About Reyvow